| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.67B | +0.6% |
| Gross Profit | $8.21B | +3.6% |
| R&D Expense | $1.31B | +8.8% |
| SG&A Expense | $4.27B | -0.3% |
| Operating Income | $2.63B | +7.8% |
| Interest Expense | $504.0M | -7.0% |
| Pre-tax Income | $2.58B | +9.3% |
| Income Tax | $531.0M | -28.5% |
| Net Income | $1.99B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.87B | +15.2% |
| Inventory | $1.94B | -1.1% |
| Current Assets | $9.90B | +5.2% |
| Total Assets | $33.09B | +2.0% |
| Current Liabilities | $9.55B | +6.4% |
| Long-term Debt | $8.95B | -5.2% |
| Total Liabilities | $24.44B | -2.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Investing Cash Flow | -$914.0M | -63.8% |
| Financing Cash Flow | -$573.0M | -19.9% |
| +27.1% |
| EPS (Basic) | $4.37 | +43.3% |
| EPS (Diluted) | $4.34 | +43.2% |
| Stockholders' Equity |
| $8.45B |
| +18.4% |